미생물 배양 시장 : 시장 규모, 점유율 및 동향 분석 보고서 - 제품별, 용도별, 유형별, 지역별, 부문 예측(2025-2033년)

Microbiology Culture Market Summary

The global microbiology culture market size was estimated at USD 10.25 billion in 2024 and is projected to reach USD 22.33 billion by 2033, growing at a CAGR of 9.16% from 2025 to 2033. The market growth is primarily driven by factors such as the rising prevalence of infectious diseases, increasing demand for rapid diagnostic solutions, and the growing adoption of advanced microbiological techniques in clinical, pharmaceutical, and research laboratories.

Advancements in microbiology techniques

Advances in microbial practices have notably accelerated the growth of the global microbiology culture industry. The traditional culture practice has received more interplay with automation, increased speed, specimen throughput systems, and molecular microbiology instruments, allowing laboratory users to culture and process larger volumes of more specific sample types. In addition, automated culture systems lessen human error, improve repeatability, and ease workflows in collecting complex clinical, research, and industry quality tests, accelerating usability. The technical growth aspect alone has made culture-based diagnostics quicker, more reliable, and accessible, further supporting the growth of high-quality culture media worldwide.

Aspects of modern molecular techniques, including PCR-based assays and genetic analyzers, can aid in rapidly identifying pathogens and novel drug-resistant strains. Advanced techniques in traditional microbiology cultures can increase diagnostic accuracy and speed critical thinking and decision-making in clinical and research settings. The growth of these laboratory applications for improved efficiency, speed, and accuracy will likely increase the demand for advanced and high-quality culture media, with technological advances continuing to support the growth of the global microbiology culture industry.

Global Microbiology Culture Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global microbiology culture market report based on product, type, application, and region

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Culture Media
• Instruments
• Reagents & Consumables
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Bacterial
• Fungal & Yeast
• Viral
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biopharmaceutical Production
• Diagnostics
• Food & Water Testing
• Environmental, Bioenergy & Agricultural Research
• Cosmetics and Personal Care Applications
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. Application
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Advancements in microbiology techniques
    • 3.3.1.2. Growth in clinical diagnostics
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. Manufacturing and scalability
    • 3.3.2.2. High cost of development
• 3.4. Business Environment Analysis
  • 3.4.1. PESTLE Analysis
  • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Microbiology Culture Market Product, Movement Analysis
• 4.3. Global Microbiology Culture Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Culture Media
  • 4.4.1. Global culture media market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Instruments
  • 4.5.1. Global instruments market estimates and forecasts, 2021 - 2033 (USD million)
• 4.6. Reagents & Consumables
  • 4.6.1. Global reagents & consumables market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 5. Type Business Analysis

• 5.1. Type Segment Dashboard
• 5.2. Global Microbiology Culture Market Type, Movement Analysis
• 5.3. Global Microbiology Culture Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 5.4. Bacterial
  • 5.4.1. Global bacterial market estimates and forecasts, 2021 - 2033 (USD million)
• 5.5. Fungal & Yeast
  • 5.5.1. Global fungal & yeast market estimates and forecasts, 2021 - 2033 (USD million)
• 5.6. Viral
  • 5.6.1. Global viral market estimates and forecasts, 2021 - 2033 (USD million)
• 5.7. Others
  • 5.7.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 6. Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global Microbiology Culture Market Application, Movement Analysis
• 6.3. Global Microbiology Culture Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Pharmaceutical & Biopharmaceutical Production
  • 6.4.1. Global pharmaceutical & biopharmaceutical production market estimates and forecasts, 2021 - 2033 (USD million)
• 6.5. Diagnostics
  • 6.5.1. Global diagnostics market estimates and forecasts, 2021 - 2033 (USD million)
• 6.6. Food & Water Testing
  • 6.6.1. Global food & water testing market estimates and forecasts, 2021 - 2033 (USD million)
• 6.7. Environmental, Bioenergy & Agricultural Research
  • 6.7.1. Global environmental, bioenergy & agricultural research market estimates and forecasts, 2021 - 2033 (USD million)
• 6.8. Cosmetics and Personal Care Applications
  • 6.8.1. Global cosmetics and personal care applications market estimates and forecasts, 2021 - 2033 (USD million)
• 6.9. Others
  • 6.9.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 7. Microbiology Culture Market: Regional Estimates and Trend Analysis, by Product, Culture & Application

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America microbiology culture market, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Target Disease Prevalence
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. Regulatory Framework
    • 7.3.2.5. U.S. microbiology culture market, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Target Disease Prevalence
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Regulatory Framework
    • 7.3.3.5. Canada microbiology culture market, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Target Disease Prevalence
    • 7.3.4.3. Competitive Scenario
    • 7.3.4.4. Regulatory Framework
    • 7.3.4.5. Mexico microbiology culture market, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe microbiology culture market, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Target Disease Prevalence
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Regulatory Framework
    • 7.4.2.5. UK microbiology culture market, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Regulatory Framework
    • 7.4.3.5. Germany microbiology culture market, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. Regulatory Framework
    • 7.4.4.5. France microbiology culture market, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Target Disease Prevalence
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Regulatory Framework
    • 7.4.5.5. Italy microbiology culture market, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Target Disease Prevalence
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
    • 7.4.6.5. Spain microbiology culture market, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Target Disease Prevalence
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Regulatory Framework
    • 7.4.7.5. Denmark microbiology culture market, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Target Disease Prevalence
    • 7.4.8.3. Competitive Scenario
    • 7.4.8.4. Regulatory Framework
    • 7.4.8.5. Sweden microbiology culture market, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Target Disease Prevalence
    • 7.4.9.3. Competitive Scenario
    • 7.4.9.4. Regulatory Framework
    • 7.4.9.5. Norway microbiology culture market, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific microbiology culture market, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Target Disease Prevalence
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Regulatory Framework
    • 7.5.2.5. Japan microbiology culture market, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Regulatory Framework
    • 7.5.3.5. China microbiology culture market, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Target Disease Prevalence
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Regulatory Framework
    • 7.5.4.5. India microbiology culture market, 2021 - 2033 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Target Disease Prevalence
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Regulatory Framework
    • 7.5.5.5. Australia microbiology culture market, 2021 - 2033 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Target Disease Prevalence
    • 7.5.6.3. Competitive Scenario
    • 7.5.6.4. Regulatory Framework
    • 7.5.6.5. Thailand microbiology culture market, 2021 - 2033 (USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Target Disease Prevalence
    • 7.5.7.3. Competitive Scenario
    • 7.5.7.4. Regulatory Framework
    • 7.5.7.5. South Korea microbiology culture market, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America microbiology culture market, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Target Disease Prevalence
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Regulatory Framework
    • 7.6.2.5. Brazil microbiology culture market, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Regulatory Framework
    • 7.6.3.5. Argentina microbiology culture market, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA microbiology culture market, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Target Disease Prevalence
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Regulatory Framework
    • 7.7.2.5. South Africa microbiology culture market, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Target Disease Prevalence
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. Regulatory Framework
    • 7.7.3.5. Saudi Arabia microbiology culture market, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Target Disease Prevalence
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Regulatory Framework
    • 7.7.4.5. UAE microbiology culture market, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Target Disease Prevalence
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. Regulatory Framework
    • 7.7.5.5. Kuwait microbiology culture market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Thermo Fisher Scientific Inc.
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Merck KGaA
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. bioMerieux SA
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. BD
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Bio-Rad Laboratories, Inc.
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Neogen Corporation
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. HiMedia Laboratories
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Hardy Diagnostics
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Amerigo Scientific.
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives